These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32170099)

  • 21. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.
    Capello D; Fais F; Vivenza D; Migliaretti G; Chiorazzi N; Gaidano G; Ferrarini M
    Leukemia; 2000 May; 14(5):811-5. PubMed ID: 10803511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.
    Song L; Wörmann S; Ai J; Neuhöfer P; Lesina M; Diakopoulos KN; Ruess D; Treiber M; Witt H; Bassermann F; Halangk W; Steiner JM; Esposito I; Rosendahl J; Schmid RM; Riemann M; Algül H
    Gastroenterology; 2016 Feb; 150(2):499-512.e20. PubMed ID: 26526716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
    Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
    Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide enhances Wnt5a expression through toll-like receptor 4, myeloid differentiating factor 88, phosphatidylinositol 3-OH kinase/AKT and nuclear factor kappa B pathways in human dental pulp stem cells.
    He W; Wang Z; Zhou Z; Zhang Y; Zhu Q; Wei K; Lin Y; Cooper PR; Smith AJ; Yu Q
    J Endod; 2014 Jan; 40(1):69-75. PubMed ID: 24331994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the phenotype and cell derivation of B cell chronic lymphocytic leukemia.
    Klein U; Dalla-Favera R
    Curr Top Microbiol Immunol; 2005; 294():31-49. PubMed ID: 16329192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.
    Cuní S; Pérez-Aciego P; Pérez-Chacón G; Vargas JA; Sánchez A; Martín-Saavedra FM; Ballester S; García-Marco J; Jordá J; Durántez A
    Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
    Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
    EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
    Knittel G; Liedgens P; Korovkina D; Seeger JM; Al-Baldawi Y; Al-Maarri M; Fritz C; Vlantis K; Bezhanova S; Scheel AH; Wolz OO; Reimann M; Möller P; López C; Schlesner M; Lohneis P; Weber AN; Trümper L; ; Staudt LM; Ortmann M; Pasparakis M; Siebert R; Schmitt CA; Klatt AR; Wunderlich FT; Schäfer SC; Persigehl T; Montesinos-Rongen M; Odenthal M; Büttner R; Frenzel LP; Kashkar H; Reinhardt HC
    Blood; 2016 Jun; 127(22):2732-41. PubMed ID: 27048211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
    Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
    Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets.
    Bendall HH; Sikes ML; Ballard DW; Oltz EM
    Mol Immunol; 1999 Feb; 36(3):187-95. PubMed ID: 10403484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
    Hammadi A; Billard C; Faussat AM; Kolb JP
    Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IkappaBepsilon-deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis.
    Mémet S; Laouini D; Epinat JC; Whiteside ST; Goudeau B; Philpott D; Kayal S; Sansonetti PJ; Berche P; Kanellopoulos J; Israël A
    J Immunol; 1999 Dec; 163(11):5994-6005. PubMed ID: 10570287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
    Loniewski KJ; Patial S; Parameswaran N
    Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt5a is secreted by follicular dendritic cells to protect germinal center B cells via Wnt/Ca2+/NFAT/NF-κB-B cell lymphoma 6 signaling.
    Kim J; Kim DW; Chang W; Choe J; Kim J; Park CS; Song K; Lee I
    J Immunol; 2012 Jan; 188(1):182-9. PubMed ID: 22124122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes.
    Airoldi I; Raffaghello L; Cocco C; Guglielmino R; Roncella S; Fedeli F; Gambini C; Pistoia V
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):144-54. PubMed ID: 14734463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
    Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
    Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B.
    Asehnoune K; Strassheim D; Mitra S; Kim JY; Abraham E
    J Immunol; 2004 Feb; 172(4):2522-9. PubMed ID: 14764725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy.
    Fox LC; Yannakou CK; Ryland G; Lade S; Dickinson M; Campbell BA; Prince HM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
    Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
    Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.